Thomson Medical granted 3 months extension to restore public float

SGX previously rejected the company’s appeal for an extension.

SGX granted Thomson Medical an additional three months until 10 April 2024, to restore its public float under Rule 723 of the SGX-ST Listing Manual.

The grant comes after the company's appeal on 12 January.

The company also appealed for an extension on 2 January, but SGX rejected the proposed extension.

Thomson Medical’s public shares dipped to 9.98% in September 2023.

SGX gave the healthcare provider an initial three months and an extension of one month to restore their public float.

The company had applied for a grace period to restore its public float thrice.

Follow the link for more news on

Thomson Medical

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia